(0.01%) 5 469.85 points
(-0.01%) 39 109 points
(0.30%) 17 772 points
(-0.53%) $80.40
(-4.50%) $2.63
(-0.86%) $2 310.70
(-0.05%) $28.86
(2.29%) $1 009.00
(0.28%) $0.936
(0.65%) $10.67
(0.47%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck...
Stats | |
---|---|
Today's Volume | 2.56M |
Average Volume | 85 425 |
Market Cap | 1.05M |
EPS | $-1.230 ( Q1 | 2024-05-14 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0726 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0450 (21.94%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-01 | Luther Sanjeev | Buy | 1 685 218 | Stock Option (right to buy) |
2024-01-01 | Clarke Dorothy J | Buy | 168 521 | Stock Option (right to buy) |
2024-01-01 | Luther Sanjeev | Buy | 0 | |
2023-12-14 | Cherington Charles | Buy | 3 125 976 | Warrants (right to buy) |
2023-12-14 | Cherington Charles | Buy | 2 307 692 | Warrants (right to buy) |
INSIDER POWER |
---|
64.63 |
Last 79 transactions |
Buy: 23 565 099 | Sell: 3 570 325 |
Volume Correlation
Eterna Therapeutics Inc. Correlation
10 Most Negative Correlations | |
---|---|
GLEE | -0.901 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Eterna Therapeutics Inc. Correlation - Currency/Commodity
Eterna Therapeutics Inc. Financials
Annual | 2023 |
Revenue: | $68 000.00 |
Gross Profit: | $-1.29M (-1 898.53 %) |
EPS: | $-4.08 |
FY | 2023 |
Revenue: | $68 000.00 |
Gross Profit: | $-1.29M (-1 898.53 %) |
EPS: | $-4.08 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-497 000 (0.00 %) |
EPS: | $-8.06 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-56.40 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Eterna Therapeutics Inc.
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators